Peter Radovich
2020
In 2020, Peter Radovich earned a total compensation of $2.6M as Chief Operating Officer at Mirum Pharmaceuticals.
Compensation breakdown
| Bonus | $111,197 |
|---|---|
| Option Awards | $2,255,631 |
| Salary | $277,992 |
| Total | $2,644,820 |
Radovich received $2.3M in option awards, accounting for 85% of the total pay in 2020.
Radovich also received $111.2K in bonus and $278K in salary.
Rankings
In 2020, Peter Radovich's compensation ranked 4,337th out of 13,090 executives tracked by ExecPay. In other words, Radovich earned more than 66.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,337 out of 13,090 | 67th |
Division Manufacturing | 1,759 out of 5,624 | 69th |
Major group Chemicals And Allied Products | 687 out of 2,257 | 70th |
Industry group Drugs | 588 out of 1,957 | 70th |
Industry Pharmaceutical Preparations | 448 out of 1,462 | 69th |
Source: SEC filing on April 14, 2021.
Radovich's colleagues
We found two more compensation records of executives who worked with Peter Radovich at Mirum Pharmaceuticals in 2020.
News
Mirum Pharmaceuticals CEO Christopher Peetz's 2023 pay jumps 47% to $6.5M
April 23, 2024
Mirum Pharmaceuticals CEO Christopher Peetz's 2022 pay rises 7% to $4.4M
May 1, 2023
Mirum Pharmaceuticals CEO Christopher Peetz's 2021 pay jumps 38% to $4.1M
April 22, 2022
Mirum Pharmaceuticals CEO Christopher Peetz's 2020 pay falls 52% to $3M
April 14, 2021